TENX Tenax Therapeutics Inc
Company Analysis
Latest News
🟢 Tenax Therapeutics is trading 10.43% up — catalyst remains unclear
Tenax Therapeutics is trading 10.43% higher at $1.80 on October 22, 2026, with no verified company announcement explaining the gain. - A report published...
🟢 Tenax Therapeutics is trading 5.83% up; no verified company explanation surfaced
Tenax Therapeutics is trading at $1.73, up 5.83%, with no verified company announcement explaining the gain. - A report published October 22 disclosed that...
🟢 Tenax Therapeutics is trading 7.4% up in after-hours trading
Tenax Therapeutics is trading at $1.75, up 7.36% after hours; no verified company-specific announcement dated October 21, 2026 explains the rise. - Reported...
🟢 Tenax Therapeutics is trading 5.6% up today amid broader biotech-sector strength
Tenax Therapeutics is trading at $1.60, up 5.59%, with broader biotech-sector strength offering a possible tailwind. - No verified company-specific...
🟢 Tenax Therapeutics is trading 10.29% up today amid rebounds in tech stocks and Nasdaq futures
Tenax Therapeutics is trading at $1.50, up 10.29%; a broader rebound in technology stocks and Nasdaq futures may be a market-sentiment factor. - No verified...
🟢 Tenax Therapeutics is trading 6.6% up in pre-market with no verified company-specific catalyst
Tenax Therapeutics is trading 6.6% up in pre-market at $1.45, with no verified company-specific announcement explaining the move. - This compares with its...
🟢 Tenax Therapeutics is trading 10.29% up today
Tenax Therapeutics is trading at $1.50 (10.29% up) with no verified company-specific news explaining the current upward move. • The stock is trading higher...
🟢 Tenax Therapeutics is trading 6.2% up in after-hours trading with no clear catalyst confirmed
Tenax Therapeutics is trading 6.2% higher at $1.44, with no verified October 16 announcement explaining the after-hours rebound. - It closed at $1.36 on...
🔴 Tenax Therapeutics is trading 6.3% down today amid biotech weakness
Tenax Therapeutics is trading at $1.42, down 6.29%, amid biotech and broader-market weakness. - The XBI is down 2.06%. - No new company-specific announcement...
Tenax Therapeutics Sees Sphera Boost Stake 33.6%
Reports dated October 15, 2026, said Sphera Funds Management Ltd. increased its investment in Tenax Therapeutics. Sphera acquired an additional 669,800 shares...
🔴 Tenax Therapeutics is trading 7.2% down today with no clear new company-specific catalyst
Tenax Therapeutics is trading at $1.70, down 7.21%, with no clear new company-specific catalyst identified for October 13. • XBI fell 2.01% during the regular...
Tenax Therapeutics Pauses Enrollment to Amend Phase 3 LEVEL-2 Trial Protocol
Tenax Therapeutics has temporarily paused enrollment in its Phase 3 LEVEL-2 clinical trial for its drug candidate TNX-103 (levosimendan) in patients with...
🟢 Tenax Therapeutics is trading 5% up today as XBI gains 2.55%
Tenax Therapeutics is trading at $1.95, up 5.01% amid biotech-sector strength, with XBI up 2.55% and outperforming the broader market on September 18, 2026. -...
Tenax Therapeutics Insiders Buy Shares, Signaling Confidence After Trial Setback
Tenax Therapeutics CEO Christopher Giordano and CFO Thomas R. Staab II purchased company stock in open-market transactions. Giordano acquired 10,850 shares on...
🔴 Tenax Therapeutics is trading 5% down today amid broader risk-off trading
Tenax Therapeutics is trading 5% down at $2.02, with the decline appearing primarily linked to broader risk-off trading. - Shares rose 7.58% to $2.13 on...
ADAR1 Keeps Buying as Tenax Pitches a Comeback Story — But Can a Failed Trial Really Be Reframed Into a Win?
Shares of Tenax Therapeutics jumped +7.6% to $2.13 on a broadly weaker market day as two catalysts converged: CEO Chris Giordano took the stage at the 12th...
🟢 Tenax Therapeutics is trading 11.36% up today following updated Phase 3 LEVEL trial results at Cantor conference
Tenax Therapeutics is trading 11.36% up at $2.21 as investor interest increased following its September 9, 2026 presentation at the Cantor Global Healthcare...
🟢 Tenax Therapeutics is trading 7.6% up today ahead of its September 9 conference presentation
Tenax Therapeutics is trading at $2.13, up +7.58%, on renewed investor interest ahead of its September 9, 2026 Cantor Global Healthcare Conference...
Tenax Therapeutics Stake Hits 15%, Signaling Confidence Ahead of Conference
ADAR1 Capital Management, LLC significantly increased its ownership stake in Tenax Therapeutics, Inc. (NASDAQ:TENX). The firm purchased 770,333 shares on...
🟢 Tenax Therapeutics is trading 5.05% up in pre-market ahead of Cantor Global Healthcare Conference
Tenax Therapeutics is trading at $2.08 (+5.05%) in pre-market; investor interest may be supported by its scheduled presentation, though no verified September...